Patents by Inventor Catherine Ranin

Catherine Ranin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240057605
    Abstract: New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art.
    Type: Application
    Filed: September 14, 2023
    Publication date: February 22, 2024
    Inventors: Hong LIU, Michael R. Welsh, Paul Nicholson, Jeffrey A. Cook, Catherine Ranin, Sandra L. Shinn, Robert F. Pepper
  • Patent number: 9801377
    Abstract: New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art.
    Type: Grant
    Filed: June 18, 2013
    Date of Patent: October 31, 2017
    Assignee: FMC Corporation
    Inventors: Hong Liu, Michael R. Welch, Paul Nicholson, Jeffrey A. Cook, Catherine Ranin, Sandra L. Shinn, Robert F. Pepper
  • Publication number: 20160135462
    Abstract: New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art.
    Type: Application
    Filed: January 22, 2016
    Publication date: May 19, 2016
    Inventors: Hong Liu, Michael R. Welsh, Paul Nicholson, Jeffrey A. Cook, Catherine Ranin, Sandra L. Shinn, Robert F. Pepper
  • Publication number: 20140031231
    Abstract: New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art.
    Type: Application
    Filed: June 18, 2013
    Publication date: January 30, 2014
    Inventors: Hong Liu, Michael R. Welch, Paul Nicholson, Jeffrey A. Cook, Catherine Ranin, Sandra L. Shinn, Robert F. Pepper